Dr. McKee’s career over the past 20 years has been directed at developing effective sex-appropriate treatments for addiction, with an emphasis on alcohol and tobacco. Her translational work spans human laboratory paradigms, clinical trials, survey research, and epidemiological research to uncover the mechanisms underlying poor outcomes and to translate these findings into improved interventions for women and men. Dr. McKee has been continuously NIH-funded as a PI over the last 20 years, with much of this work focused on medication development for alcohol and tobacco use disorders. She has held national leadership positions in the field of addiction (APA, Division 50 President), and her research efforts recognized by RSA, APA, NIDA, SRNT, and NARSAD.
Scientific Advisory Board
Neil Grunberg, Ph.D.
Professor of Medical & Clinical Psychology and Neuroscience
Uniformed Services University of the Health Sciences
Caryn Lerman, Ph.D.
Mary W. Calkins Professor of Psychology in Psychiatry
Interim Director of the Abramson Cancer Center
University of Pennsylvania
Edythe London, Ph.D.
Thomas P. and Katherine K. Pike Professor of Addiction Studies
Professor of Psychiatry and Molecular and Medical Pharmacology
David Geffen School of Medicine
University of California, Los Angeles
Maxine L. Stitzer, Ph.D.
Professor of Behavioral Biology
John Hopkins University School of Medicine